Results 111 to 120 of about 2,782 (157)

The gut-brain axis in avian appetite regulation: Integrating peripheral signals with central neurocircuitry. [PDF]

Poult Sci
Mahdavi K, Zendehdel M, Ghashghaei E, Lin H.   +3 more
europepmc   +1 more source

Central pramlintide administration potently suppresses operant responding for sucrose and locomotor activity in male rats. [PDF]

Physiol Behav
Kern KA, DiBrog AM, Demieri E, Przybysz JT, Clark SD, Mietlicki-Baase EG.   +5 more
europepmc   +1 more source

Efficacy and safety of incretin co-agonists: Transformative advances in cardiometabolic healthcare. [PDF]

World J Cardiol
Bhat S, Fernandez CJ, Lakshmi V, Pappachan JM.   +3 more
europepmc   +1 more source

Biomarkers and Endothelial Damage in Obesity: An Insight into the Pharmacological Modulation. [PDF]

Int J Mol Sci
Bojórquez-González AY, Gómez-Sánchez E, Suarez-Rico DO, Beltrán-Ramírez A, Balleza-Alejandri LR, López-Murillo LD, Ramírez-Lizardo EJ, García-Galindo JJ.   +7 more
europepmc   +1 more source

The Role of Antidiabetic Therapies in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review of Metformin, Pioglitazone, and GLP-1 Receptor Agonists. [PDF]

Int J Mol Sci
Mahoon DA, Hamad O, Butler AE.
europepmc   +1 more source

Neuroendocrinology meets addiction: Emerging pharmacotherapies on the horizon. [PDF]

J Intern Med
Loften A, Farokhnia M, Vendruscolo LF, Leggio L.   +3 more
europepmc   +1 more source

Discovery of peptides as key regulators of metabolic and cardiovascular crosstalk. [PDF]

Cell Rep
Zhang Z, Svensson KJ.
europepmc   +1 more source

GLP-1 Receptor Agonists for Treating Alcohol Use Disorder: A Critical Review. [PDF]

Alcohol Clin Exp Res (Hoboken)
Woo S, Zhu G, Castro C, Phuong A, Roy A, Davis CN, Kranzler HR.   +6 more
europepmc   +1 more source

Research progress in precision medicine for type 2 diabetes based on the GLP-1. [PDF]

Front Endocrinol (Lausanne)
Wang S, Yuan C, Wang H, Ye X, Ruan S, Yi L, Yang W, Wang Z, Wang N, Li J, Feng X, Li Y, Tian Y, Wang Q.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Structural insight into selectivity of amylin and calcitonin receptor agonists

Nature Chemical Biology, 2023
Amylin receptors (AMYRs), heterodimers of the calcitonin receptor (CTR) and one of three receptor activity-modifying proteins, are promising obesity targets. A hallmark of AMYR activation by Amy is the formation of a 'bypass' secondary structural motif (residues S19-P25).
Radostin Danev, Patrick Sexton, Jianjun Cao   +2 more
exaly   +3 more sources